INBX
Inhibrx Biosciences, Inc.
$128.84-2.61 (-1.99%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Inhibrx Biosciences, Inc. (INBX) is a publicly traded company with 1 insider transaction disclosed via SEC Form 4 in the past 90 days, involving 1 unique insider. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
8 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | 2026-04-24 | Matly David | President | Award | 50,000 | $129.06 | $6,453,000 | N/A | N/A |
| 2025-10-09 | 2025-10-07 | Viking Global Investors Lp | 10% Owner | Sale | 308,643 | $32.25 | -$9,953,737 | N/A | N/A |
| 2025-10-09 | 2025-10-07 | Viking Global Investors Lp | 10% Owner | Sale | 16,315 | $32.25 | -$526,159 | N/A | N/A |
| 2025-10-09 | 2025-10-07 | Viking Global Investors Lp | 10% Owner | Sale | 25,042 | $32.25 | -$807,605 | N/A | N/A |
| 2025-05-29 | 2025-05-28 | Vuori Kristiina Md | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-29 | 2025-05-28 | Manhard Kimberly | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-29 | 2025-05-28 | Forsyth Douglas | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-29 | 2025-05-28 | Kayyem Jon Faiz | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
INBX
10% Owner
Sale
-$10M
Viking Global Investors Lp308,643 shares @ $32.25
Filed 2025-10-09Trade 2025-10-07
INBX
10% Owner
Sale
-$526.2K
Viking Global Investors Lp16,315 shares @ $32.25
Filed 2025-10-09Trade 2025-10-07
INBX
10% Owner
Sale
-$807.6K
Viking Global Investors Lp25,042 shares @ $32.25
Filed 2025-10-09Trade 2025-10-07